Page last updated: 2024-09-05

lapatinib and Cancer of Gallbladder

lapatinib has been researched along with Cancer of Gallbladder in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Jing, Y; Liu, F; Liu, Y; Lu, Z; Lv, J; Shao, YW; Sun, A; Tao, F; Wang, W; Wu, X; Xu, G; Ye, M	1

Other Studies

1 other study(ies) available for lapatinib and Cancer of Gallbladder

Article	Year
Dual-targeting strategy using trastuzumab and lapatinib in a patient with HER2 gene amplification in recurrent metachronous metastatic gallbladder carcinoma. The Journal of international medical research, 2019, Volume: 47, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Female; Gallbladder Neoplasms; Gene Amplification; Humans; Lapatinib; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Receptor, ErbB-2; Trastuzumab	2019

Article

Year

Dual-targeting strategy using trastuzumab and lapatinib in a patient with HER2 gene amplification in recurrent metachronous metastatic gallbladder carcinoma.

The Journal of international medical research, 2019, Volume: 47, Issue:6

Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Female; Gallbladder Neoplasms; Gene Amplification; Humans; Lapatinib; Middle Aged; Neoplasm Recurrence, Local; Prognosis; Receptor, ErbB-2; Trastuzumab

2019